Insider filing · INBX
Douglas Forsyth bought $287K of Inhibrx Biosciences (INBX)
Executed Sep 8, disclosed Sep 8, the same day.
Value, as filed
$287K
2,500 sh × $114.65
Executed
Sep 8
the trade date, as filed
Disclosed
Sep 8
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
DF
Douglas Forsyth
Director
profile →
Douglas Forsyth (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Inhibrx Biosciences, Inc. (INBX). The largest single filing was $287K of INBX (2,500 sh × $114.65, as filed), executed Sep 8. The median gap between execution and disclosure was 0 days.
The name
INBX
Inhibrx Biosciences, Inc.
INBX · Healthcare · 7 filings in 24 months
ticker →
Healthcare · Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→